New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 3, 2014
10:41 EDTNPSP, MNKD, PVA, TSN, CLOptions with increasing implied volatility: NPSP MNKD PVA TSN CL
News For NPSP;MNKD;PVA;TSN;CL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
October 24, 2014
07:05 EDTCLColgate-Palmolive reports Q3 organic sales growth up 3.5%
Subscribe for More Information
07:03 EDTCLColgate-Palmolive reports Q3 EPS ex-items 76c, consensus 76c
Reports Q3 revenue $4.379B, consensus $4.44B.
05:54 EDTNPSPStocks with implied volatility movement; NPSP HLF
Subscribe for More Information
October 23, 2014
18:52 EDTNPSPOn The Fly: After Hours Movers
UP AFTER EARNINGS: Rubicon Project (RUBI), up 19.2%... KLA-Tencor (KLAC), up 15.8%... Gigamon (GIMO), up 13.5%... Maxwell (MXWL), up 11.3%... Qlik Technologies (QLIK), up 9.8%... NetSuite (N), up 5.5%... Microsoft (MSFT), up 3.3%... Juniper Networks (JNPR), reverses in after-hours trading and is up 1.4% after reporting third quarter results and announcing a $1.1B increase to the company's share repurchase authorization. ALSO HIGHER: Vitae Pharmaceuticals (VTAE), up 38.6% following positive top-line results from two Phase 1 clinical trials of BI1181181/VTP-37948... Pfizer (PFE), up 1.8% after announcing a new $11B share repurchase program. DOWN AFTER EARNINGS: Amazon.com (AMZN), down 10.7%... Synaptics(SYNA), down 12.7%... Pandora (P), down 6.8%... Lattice Semiconductor (LSCC), down 5.6%... Maxim Integrated (MXIM), down 5.8%. ALSO LOWER: DryShips (DRYS), down 16.5% after filing an automatic common stock shelf... NPS Pharmaceuticals (NPSP), down 7.9% following PDUFA date for Natpara extended three months to January 24... GoPro (GPRO), down 2.8% after being initiated with an Underperform at Oppenheimer.
16:47 EDTNPSPNPS Pharmaceuticals PDUFA date for Natpara extended three months to January 24
NPS Pharmaceuticals reported that the FDA has extended the company’s Prescription Drug User Fee Act, or PDUFA, action date for its Natpara Biologics License Application by three months from October 24 to January 24, 2015. The FDA extended the action date to provide time for a full review of a major amendment; such extensions are provided for by regulation. In addition, the FDA requested that NPS Pharma submit a Risk Evaluation and Mitigation Strategy, or REMS, for Natpara and the company is working to finalize the REMS in advance of the revised PDUFA action date. To date, the FDA has not requested that additional clinical studies be completed prior to the approval of Natpara; however, the company expects a post-approval study commitment. Francois Nader CEO of NPS Pharma said, “We continue to advance our commercial readiness activities and are planning for the launch of Natpara in 2Q15.”
15:39 EDTCLNotable companies reporting before tomorrow's open
Subscribe for More Information
10:01 EDTPVAOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:01 EDTPVAPenn Virginia initiated with a Neutral at Susquehanna
Subscribe for More Information
October 22, 2014
12:19 EDTPVAOptions with decreasing implied volatility
Subscribe for More Information
05:58 EDTMNKDStocks with implied volatility movement; MNKD SHPG
Subscribe for More Information
October 21, 2014
09:48 EDTNPSPShire could target BioMarin, TheStreet's Feuerstein says
Subscribe for More Information
October 20, 2014
09:22 EDTNPSPOn The Fly: Pre-market Movers
Subscribe for More Information
06:56 EDTNPSPShire reopens acquistion talks with NPS Pharmaceuticals, Cubist, Telegraph says
Subscribe for More Information
06:52 EDTMNKDMannKind initiated with a Neutral at Goldman
Target $6.
October 17, 2014
09:07 EDTTSNProtein stock pullback on Sanderson comments overdone, says BMO Capital
BMO Capital views yesterday's decline in Sanderson Farms (SAFM), Pilgrim's Pride (PPC) and Tyson Foods (TSN) as an overreaction to Sanderson's comments regarding breast prices falling to year-ago levels for the next four months. BMO notes that breast prices always dip in the fall. Following Sanderson's investor day, BMO said it sees a greater probability of chicken margins remaining at near-record levels in 2015. It keeps an Outperform rating on the stock.
07:39 EDTTSNChicken stock sell-off yesterday overdone, says JPMorgan
Subscribe for More Information
October 16, 2014
15:35 EDTTSNSanderson Farms falls following investor day meeting
Subscribe for More Information
11:36 EDTPVAOptions with increasing implied volatility
Options with increasing implied volatility: UVXY NQ PVA SVXY VXX SUNE CIE COV ZU CODE
October 14, 2014
11:28 EDTPVAOptions with increasing implied volatility
Subscribe for More Information
October 13, 2014
12:33 EDTPVAOptions with increasing implied volatility
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use